The Effect of Chair Yoga in Older Adults with Moderate and Severe Alzheimer's Disease

被引:23
|
作者
McCaffrey, Ruth [1 ]
Park, Juyoung [2 ]
Newman, David [1 ]
Hagen, Dyana [2 ]
机构
[1] Florida Atlantic Univ, Christine E Lynn Coll Nursing, Boca Raton, FL 33431 USA
[2] Florida Atlantic Univ, Sch Social Work, Boca Raton, FL 33431 USA
关键词
BENEFITS; MILD; GAIT;
D O I
10.3928/19404921-20140218-01
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Using a quasi-experimental single-group design, this study examined the feasibility of older adults with Alzheimer's disease (AD)-type dementia to complete the Sit 'N' Fit Chair Yoga Program. Physical function of participants who completed the program was measured. The nine older adults with AD (mean age = 83) participated in the 8-week Sit 'N' Fit Chair Yoga Program. To measure physical function, the Six-Minute Walk Test, the Gait Speed Test, and the Berg Balance Scale were administered at preintervention, 4 weeks, 8 weeks, and 1 month after program completion. All participants completed the program. Positive changes were seen across all physical measures. Further study, using a larger sample and including a control group, is needed to fully determine the effect of the Sit'N' Fit Chair Yoga Program on older adults with moderate to severe AD.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 50 条
  • [21] The effect of memantine on distinct behaviour syndromes in moderate to severe Alzheimer's disease patients
    Blau, A.
    Cummings, J. L.
    Olin, J. T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S481 - S481
  • [22] Effect of donepezil on bone metabolism among older adults with Alzheimer's disease
    North, Rebecca
    Liu, Andy J.
    Pieper, Carl
    Danus, Susanne
    Thacker, Connie R.
    Ashner, Marissa
    Colon-Emeric, Cathleen
    Lee, Richard H.
    CONTEMPORARY CLINICAL TRIALS, 2025, 148
  • [23] Responders to memantine treatment in moderate to severe Alzheimer's disease
    Stöffler, A
    Ferris, SH
    Wirth, Y
    Reisberg, B
    NEUROBIOLOGY OF AGING, 2004, 25 : S212 - S212
  • [24] Donepezil benefits patients with moderate to severe Alzheimer's disease
    Watts, Geoff
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [25] Memantine improves independence in moderate to severe Alzheimer's disease
    Guilhaume, C
    Lundbeck, H
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S207 - S208
  • [26] Memantine in moderate-to-severe Alzheimer's disease - Reply
    Reisberg, B
    Doody, R
    Mobius, HJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06): : 610 - 610
  • [27] Management of moderate to severe Alzheimer's disease: Focus on memantine
    Dominguez, Evangelyn
    Chin, Ting-Yu
    Chen, Chih-Ping
    Wu, Tzong-Yuan
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2011, 50 (04): : 415 - 423
  • [28] Memantine therapy in patients with moderate to severe Alzheimer's disease
    Ochudlo, S
    Targosz, M
    Liberska, A
    Opala, G
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 235 - 235
  • [29] Overview of memantine data in moderate to severe Alzheimer's disease
    Wilkinson, David
    NEUROBIOLOGY OF AGING, 2008, 29 : S25 - S26
  • [30] Memantine enhances autonomy in moderate to severe Alzheimer's disease
    Rive, B
    Vercelletto, M
    Damier, FD
    Cochran, J
    François, C
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (05) : 458 - 464